Joint Venture Proton Therapy Center Under Development
By MedImaging International staff writers Posted on 27 Feb 2012 |
A cancer treatment-center project, now under development in the US state of Arizona, is the latest of an ongoing effort to bring cutting-edge treatment technologies to more patients through joint-venture partnerships with physicians and hospitals.
Proton therapy is a groundbreaking cancer treatment that targets tumors with a beam of protons. By delivering doses with pinpoint precision, proton therapy is painless, non-invasive, and very effective in treating tumors while minimizing damage to surrounding healthy tissue.
Accelitech, LLC (Rosemont, IL, USA), a developer and manager of full-cycle management of technology-driven cancer treatment programs, recently announced its inaugural proton therapy project. Due to the high cost and large scope of developing a proton therapy center, there are only a small number of places in the United States where patients can receive the treatment. With recent lower cost options entering the market, Accelitech hopes to change that by using its existing model to target several proton therapy locations over the next two years.
“The technology may be new, but our model for success remains the same,” stated Kerwin Brandt, president and CEO of Accelitech. “Proton therapy is the next generation of cancer treatment, and this project is an exciting opportunity to apply our proven, full-cycle management process to making this state-of-the-art technology available to patients on a broader scale.”
Proton beam therapy is a type of external radiotherapy that targets tumors with beams of protons. It has fewer side effects than standard radiation and is proven to be effective in sensitive areas such as the head, spine, and prostate. Because of the exact localization and unique behavior of protons, higher dosages can be delivered with excellent accuracy, sparing more of the healthy tissue that surrounds the tumor. Proton beam therapy is a noninvasive, pain-free procedure that provides a reduced risk of secondary cancer incidents, making it an appealing alternative for the treatment of growing children.
Related Links:
Accelitech
Proton therapy is a groundbreaking cancer treatment that targets tumors with a beam of protons. By delivering doses with pinpoint precision, proton therapy is painless, non-invasive, and very effective in treating tumors while minimizing damage to surrounding healthy tissue.
Accelitech, LLC (Rosemont, IL, USA), a developer and manager of full-cycle management of technology-driven cancer treatment programs, recently announced its inaugural proton therapy project. Due to the high cost and large scope of developing a proton therapy center, there are only a small number of places in the United States where patients can receive the treatment. With recent lower cost options entering the market, Accelitech hopes to change that by using its existing model to target several proton therapy locations over the next two years.
“The technology may be new, but our model for success remains the same,” stated Kerwin Brandt, president and CEO of Accelitech. “Proton therapy is the next generation of cancer treatment, and this project is an exciting opportunity to apply our proven, full-cycle management process to making this state-of-the-art technology available to patients on a broader scale.”
Proton beam therapy is a type of external radiotherapy that targets tumors with beams of protons. It has fewer side effects than standard radiation and is proven to be effective in sensitive areas such as the head, spine, and prostate. Because of the exact localization and unique behavior of protons, higher dosages can be delivered with excellent accuracy, sparing more of the healthy tissue that surrounds the tumor. Proton beam therapy is a noninvasive, pain-free procedure that provides a reduced risk of secondary cancer incidents, making it an appealing alternative for the treatment of growing children.
Related Links:
Accelitech
Latest Industry News News
- GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
- Patient-Specific 3D-Printed Phantoms Transform CT Imaging
- Siemens and Sectra Collaborate on Enhancing Radiology Workflows
- Bracco Diagnostics and ColoWatch Partner to Expand Availability CRC Screening Tests Using Virtual Colonoscopy
- Mindray Partners with TeleRay to Streamline Ultrasound Delivery
- Philips and Medtronic Partner on Stroke Care
- Siemens and Medtronic Enter into Global Partnership for Advancing Spine Care Imaging Technologies
- RSNA 2024 Technical Exhibits to Showcase Latest Advances in Radiology
- Bracco Collaborates with Arrayus on Microbubble-Assisted Focused Ultrasound Therapy for Pancreatic Cancer
- Innovative Collaboration to Enhance Ischemic Stroke Detection and Elevate Standards in Diagnostic Imaging
- RSNA 2024 Registration Opens
- Microsoft collaborates with Leading Academic Medical Systems to Advance AI in Medical Imaging
- GE HealthCare Acquires Intelligent Ultrasound Group’s Clinical Artificial Intelligence Business
- Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions
- Polish Med-Tech Company BrainScan to Expand Extensively into Foreign Markets
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
Channels
Radiography
view channel
AI Radiology Tool Identifies Life-Threatening Conditions in Milliseconds
Radiology is emerging as one of healthcare’s most pressing bottlenecks. By 2033, the U.S. could face a shortage of up to 42,000 radiologists, even as imaging volumes grow by 5% annually.... Read more
Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans
A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more
AI Improves Early Detection of Interval Breast Cancers
Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more
World's Largest Class Single Crystal Diamond Radiation Detector Opens New Possibilities for Diagnostic Imaging
Diamonds possess ideal physical properties for radiation detection, such as exceptional thermal and chemical stability along with a quick response time. Made of carbon with an atomic number of six, diamonds... Read moreMRI
view channel
New MRI Technique Reveals Hidden Heart Issues
Traditional exercise stress tests conducted within an MRI machine require patients to lie flat, a position that artificially improves heart function by increasing stroke volume due to gravity-driven blood... Read more
Shorter MRI Exam Effectively Detects Cancer in Dense Breasts
Women with extremely dense breasts face a higher risk of missed breast cancer diagnoses, as dense glandular and fibrous tissue can obscure tumors on mammograms. While breast MRI is recommended for supplemental... Read moreUltrasound
view channel
New Incision-Free Technique Halts Growth of Debilitating Brain Lesions
Cerebral cavernous malformations (CCMs), also known as cavernomas, are abnormal clusters of blood vessels that can grow in the brain, spinal cord, or other parts of the body. While most cases remain asymptomatic,... Read more.jpeg)
AI-Powered Lung Ultrasound Outperforms Human Experts in Tuberculosis Diagnosis
Despite global declines in tuberculosis (TB) rates in previous years, the incidence of TB rose by 4.6% from 2020 to 2023. Early screening and rapid diagnosis are essential elements of the World Health... Read moreNuclear Medicine
view channel
New Imaging Approach Could Reduce Need for Biopsies to Monitor Prostate Cancer
Prostate cancer is the second leading cause of cancer-related death among men in the United States. However, the majority of older men diagnosed with prostate cancer have slow-growing, low-risk forms of... Read more
Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors
Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read moreGeneral/Advanced Imaging
view channel
CT Colonography Beats Stool DNA Testing for Colon Cancer Screening
As colorectal cancer remains the second leading cause of cancer-related deaths worldwide, early detection through screening is vital to reduce advanced-stage treatments and associated costs.... Read more
First-Of-Its-Kind Wearable Device Offers Revolutionary Alternative to CT Scans
Currently, patients with conditions such as heart failure, pneumonia, or respiratory distress often require multiple imaging procedures that are intermittent, disruptive, and involve high levels of radiation.... Read more
AI-Based CT Scan Analysis Predicts Early-Stage Kidney Damage Due to Cancer Treatments
Radioligand therapy, a form of targeted nuclear medicine, has recently gained attention for its potential in treating specific types of tumors. However, one of the potential side effects of this therapy... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more